Go Pro

Vyome (HIND) Financials

$2.06 -0.08 (-3.74%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$2.06 +0.00 (+0.24%)
As of 07/24/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Vyome

Annual Income Statements for Vyome

This table shows Vyome's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-16 -20 -35 -37 -24 -22 -63 -46 -11 -1.45 -10
Consolidated Net Income / (Loss)
-16 -20 -35 -37 -24 -22 -63 -46 -11 -1.45 -10
Net Income / (Loss) Continuing Operations
-16 -20 -35 -37 -24 -22 -63 -46 -11 -1.45 -10
Total Pre-Tax Income
-16 -20 -35 -37 -24 -22 -63 -47 -11 -1.45 -10
Total Operating Income
-15 -20 -34 -37 -23 -12 -58 -46 -15 -1.01 -10
Total Gross Profit
1.54 0.58 5.09 3.68 0.33 6.26 8.35 6.80 5.55 0.19 0.22
Total Revenue
4.04 3.39 9.91 9.10 3.28 11 14 11 8.68 0.26 0.32
Operating Revenue
4.04 3.39 9.91 9.10 3.28 11 14 11 8.68 0.26 0.32
Total Cost of Revenue
2.50 2.81 4.83 5.42 2.95 5.04 5.25 4.44 3.13 0.06 0.10
Operating Cost of Revenue
2.50 2.81 4.83 5.42 2.95 5.04 5.25 4.44 3.13 0.06 0.10
Total Operating Expenses
16 20 39 41 24 19 66 53 21 1.20 11
Selling, General & Admin Expense
3.49 10 29 30 17 15 33 31 10 0.90 2.37
Research & Development Expense
13 9.87 11 11 6.89 3.50 2.37 2.54 2.32 0.29 0.59
Depreciation Expense
- - - - - - - - - 0.02 0.01
Other Operating Expenses / (Income)
- - - - - - - - - 0.00 7.71
Total Other Income / (Expense), net
-0.58 -0.94 -0.14 -0.23 -0.45 -9.35 -5.54 -0.25 4.05 -0.44 -0.03
Interest Expense
- - - - - 7.72 2.06 - 0.00 0.21 0.15
Other Income / (Expense), net
-0.03 -0.47 - - -0.06 0.41 -2.65 -0.14 4.02 -0.24 0.12
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - - - - - - 0.00 -0.22
Basic Earnings per Share
($27.14) ($4.85) ($2.08) ($19.64) ($5.03) ($5.54) ($288.97) ($108.90) ($110.87) ($6,001.39) ($4.86)
Weighted Average Basic Shares Outstanding
573.18K 4.22M 16.72M 1.90M 4.71M 3.90M 218.52K 424.39K 102.71K 241.00 2.16M
Diluted Earnings per Share
($27.14) ($4.85) ($2.08) ($19.64) ($5.03) ($5.54) ($288.97) ($108.90) ($110.87) ($6,001.39) ($4.86)
Weighted Average Diluted Shares Outstanding
573.18K 4.22M 16.72M 1.90M 4.71M 3.90M 218.52K 424.39K 102.71K 241.00 2.16M

Quarterly Income Statements for Vyome

This table shows Vyome's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-3.53 -1.70 -2.19 -1.60 -0.55 2.89 -0.29 -2.63 -8.43 -0.67 -0.96
Consolidated Net Income / (Loss)
-3.53 -1.70 -2.19 -1.60 -0.55 2.89 -0.29 -2.63 -8.60 -0.73 -0.99
Net Income / (Loss) Continuing Operations
-3.53 -1.71 -2.19 -1.60 -0.55 2.89 -0.29 -2.63 -8.60 -0.73 -0.99
Total Pre-Tax Income
-3.53 -1.67 -2.18 -1.58 -0.55 2.86 -0.29 -2.62 -8.60 -0.74 -0.99
Total Operating Income
-3.88 -1.90 -2.21 -2.05 -0.28 3.54 -0.20 -2.76 -8.57 3.09 -1.13
Total Gross Profit
1.29 1.84 1.17 1.13 0.04 -2.14 0.15 0.60 0.02 -1.08 0.02
Total Revenue
2.16 1.98 1.94 1.97 0.08 -3.74 0.20 1.24 0.03 -2.07 0.03
Operating Revenue
2.16 1.98 1.94 1.97 0.08 -3.74 0.20 1.24 0.03 -2.07 0.03
Total Cost of Revenue
0.87 0.14 0.78 0.83 0.05 -1.60 0.04 0.64 0.02 -0.99 0.01
Operating Cost of Revenue
0.87 0.14 0.78 0.83 0.05 -1.60 0.04 0.64 0.02 -0.99 0.01
Total Operating Expenses
5.17 3.74 3.38 3.19 0.32 -5.68 0.35 3.36 8.59 -4.17 1.15
Selling, General & Admin Expense
3.85 -4.55 1.87 1.91 0.25 -3.13 0.26 1.59 0.84 -1.70 0.48
Research & Development Expense
0.54 0.74 0.48 0.40 0.07 -0.66 0.09 0.48 0.04 -0.29 0.67
Depreciation Expense
- - - - 0.00 - 0.00 - 0.00 - 0.00
Total Other Income / (Expense), net
0.35 0.24 0.03 0.47 -0.27 -0.68 -0.09 0.14 -0.02 -3.83 0.14
Interest Expense
0.00 - 0.00 -0.43 0.05 0.59 0.05 0.00 0.03 0.15 0.00
Other Income / (Expense), net
0.34 0.22 0.02 0.04 -0.22 -0.08 -0.04 0.12 0.00 -3.71 0.15
Net Income / (Loss) Attributable to Noncontrolling Interest
- - - - 0.00 - 0.00 - -0.16 - -0.02
Basic Earnings per Share
($59.36) ($16.53) ($135.37) ($91.56) ($1,419.10) $11,984.69 ($761.59) ($2.25) ($3.12) ($0.31) ($0.15)
Weighted Average Basic Shares Outstanding
59.54K 102.71K 16.20K 17.42K 386.00 241.00 386.00 1.17M 2.76M 2.16M 6.69M
Diluted Earnings per Share
($59.36) ($16.53) ($135.37) ($91.56) ($1,419.10) $11,984.69 ($761.59) ($2.25) ($3.12) ($0.31) ($0.15)
Weighted Average Diluted Shares Outstanding
59.54K 102.71K 16.20K 17.42K 386.00 241.00 386.00 1.17M 2.76M 2.16M 6.69M

Annual Cash Flow Statements for Vyome

This table details how cash moves in and out of Vyome's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-3.55 70 -52 0.08 -7.13 0.02 20 -19 0.60 0.08 4.88
Net Cash From Operating Activities
-11 -19 -31 -29 -23 -8.55 -15 -22 -17 -0.61 -3.75
Net Cash From Continuing Operating Activities
-11 -19 -31 -29 -23 -8.55 -15 -22 -17 -0.61 -3.75
Net Income / (Loss) Continuing Operations
-16 -20 -35 -37 -24 -22 -63 -46 -11 -1.45 -10
Consolidated Net Income / (Loss)
-16 -20 -35 -37 -24 -22 -63 -46 -11 -1.45 -10
Depreciation Expense
0.20 0.19 0.33 0.60 0.48 0.02 0.23 0.33 0.12 0.02 0.01
Non-Cash Adjustments To Reconcile Net Income
1.51 1.04 4.85 4.80 2.75 9.80 48 22 -1.62 0.43 6.68
Changes in Operating Assets and Liabilities, net
2.68 -0.33 -1.10 2.58 -2.90 -0.08 -2.96 0.29 -4.11 0.39 0.04
Net Cash From Investing Activities
2.78 6.20 -22 20 2.36 -2.39 1.86 -0.09 -0.01 0.00 0.00
Net Cash From Continuing Investing Activities
2.78 6.20 -22 20 2.36 -2.39 1.86 -0.09 -0.01 0.00 0.00
Sale of Property, Plant & Equipment
0.01 0.00 - - - - 0.00 0.04 0.03 0.00 0.00
Net Cash From Financing Activities
5.06 83 0.61 9.99 13 11 33 3.13 18 0.70 8.65
Net Cash From Continuing Financing Activities
5.06 83 0.61 9.99 13 11 33 3.13 18 0.70 8.65
Issuance of Debt
5.00 0.03 - 0.00 10 10 1.00 - 0.00 0.67 0.79
Issuance of Common Equity
0.00 67 0.43 9.97 23 - 0.00 0.64 13 0.03 1.28
Other Financing Activities, net
0.06 1.07 0.18 0.05 0.00 0.68 46 2.49 4.14 0.00 6.58

Quarterly Cash Flow Statements for Vyome

This table details how cash moves in and out of Vyome's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-3.12 3.01 -2.08 -1.33 3.44 0.05 -0.04 1.61 2.18 -0.72 3.81
Net Cash From Operating Activities
-2.78 -2.46 -2.07 -1.36 2.82 -0.00 -0.20 -4.49 4.34 -1.48 -1.44
Net Cash From Continuing Operating Activities
-2.78 -2.46 -2.07 -1.36 2.82 -0.00 -0.20 -4.49 4.34 -1.48 -1.44
Net Income / (Loss) Continuing Operations
-3.53 -1.70 -2.19 -1.60 2.65 -0.31 -0.29 -2.63 -8.04 -1.28 -0.99
Consolidated Net Income / (Loss)
-3.53 -1.70 -2.19 -1.60 2.65 -0.31 -0.29 -2.63 -8.04 -1.28 -0.99
Depreciation Expense
0.04 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income
0.92 -0.03 -0.34 -0.03 0.50 0.29 0.09 0.01 10 0.07 0.04
Changes in Operating Assets and Liabilities, net
-0.22 -0.73 0.46 0.26 -0.33 0.01 -0.00 -1.88 2.04 -0.27 -0.49
Net Cash From Investing Activities
- - 0.00 - -0.00 0.00 0.00 - - - 0.00
Net Cash From Continuing Investing Activities
- - 0.00 - -0.00 0.00 0.00 - - - 0.00
Net Cash From Financing Activities
-0.34 5.46 0.00 0.02 0.62 0.05 0.16 6.10 -2.16 0.76 5.29
Net Cash From Continuing Financing Activities
-0.34 5.46 0.00 0.02 0.62 0.05 0.16 6.10 -2.16 0.76 5.29
Issuance of Debt
- - - - - 0.05 0.16 - - - 0.00
Issuance of Common Equity
- 0.99 0.00 - 0.03 -0.00 0.00 6.10 -10 0.60 5.29
Effect of Exchange Rate Changes
- 0.01 -0.01 0.01 - - 0.00 0.00 - - -0.04
Cash Income Taxes Paid
0.00 0.01 0.01 0.00 - - 0.00 - - - 0.00

Annual Balance Sheets for Vyome

This table presents Vyome's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
14 79 53 30 20 37 53 11 11 1.38 6.50
Total Current Assets
14 78 52 29 18 8.94 30 9.91 10 0.30 5.44
Cash & Equivalents
3.36 73 21 21 14 2.96 23 3.86 4.46 0.10 4.98
Prepaid Expenses
- - - - - 1.07 1.31 0.17 0.34 0.01 0.34
Other Current Assets
0.27 1.24 1.71 2.46 1.96 - - - - 0.19 0.12
Plant, Property, & Equipment, net
0.42 0.72 1.35 1.74 1.08 0.58 1.45 0.70 0.06 0.06 0.05
Total Noncurrent Assets
0.00 0.00 0.00 0.00 1.08 28 21 0.53 0.31 1.02 1.01
Noncurrent Note & Lease Receivables
- - - - - - - - - 0.65 0.60
Intangible Assets
- - - - - 27 21 0.26 - 0.31 0.31
Other Noncurrent Operating Assets
- - - - 1.08 0.51 0.31 0.22 0.28 0.06 0.10
Total Liabilities & Shareholders' Equity
14 79 53 30 20 37 53 11 11 1.38 6.50
Total Liabilities
15 14 18 17 4.54 23 8.20 7.48 4.00 5.77 2.74
Total Current Liabilities
5.57 4.59 10 17 3.98 12 7.53 7.48 3.78 5.74 2.74
Accounts Payable
0.55 0.60 1.28 1.16 0.65 3.66 3.47 1.93 1.69 0.97 1.29
Current Employee Benefit Liabilities
1.25 2.50 4.49 3.81 0.82 - - - - 0.92 0.87
Other Current Liabilities
0.83 1.38 1.77 1.99 2.09 0.71 0.69 0.52 0.27 0.27 0.58
Total Noncurrent Liabilities
9.09 9.88 7.98 0.05 0.57 11 0.67 0.00 0.22 0.03 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-55 64 35 13 16 14 44 3.66 6.66 -4.39 3.76
Total Preferred & Common Equity
-55 64 35 13 16 14 44 3.66 6.66 -4.39 2.44
Total Common Equity
-55 64 35 13 16 14 44 3.66 6.66 -4.39 2.44
Common Stock
1.00 141 146 162 188 529 622 628 642 51 90
Retained Earnings
-56 -77 -111 -149 -172 -515 -578 -624 -636 -55 -88
Accumulated Other Comprehensive Income / (Loss)
0.00 -0.00 -0.01 - - -0.12 -0.09 -0.09 -0.09 -0.05 -0.08
Noncontrolling Interest
- - - - - - - - - 0.00 1.32

Quarterly Balance Sheets for Vyome

This table presents Vyome's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
7.83 8.23 6.39 5.62 6.48 9.03 7.05 10
Total Current Assets
7.40 7.90 6.09 5.34 6.30 8.86 6.04 9.16
Cash & Equivalents
1.45 2.38 1.05 0.74 2.52 4.12 5.71 8.80
Prepaid Expenses
0.49 0.38 0.31 0.22 0.41 0.71 0.21 0.21
Other Current Assets
- - - - - - 0.09 0.16
Plant, Property, & Equipment, net
0.07 0.05 0.05 0.04 0.03 0.03 0.05 0.04
Total Noncurrent Assets
0.36 0.28 0.26 0.23 0.15 0.14 0.96 0.98
Noncurrent Note & Lease Receivables
- - - - - - 0.61 0.58
Intangible Assets
0.00 - - - - - 0.31 0.31
Other Noncurrent Operating Assets
0.30 0.26 0.23 0.21 0.13 0.11 0.04 0.08
Total Liabilities & Shareholders' Equity
7.83 8.23 6.39 5.62 6.48 9.03 7.05 10
Total Liabilities
4.74 3.70 3.36 4.13 5.25 3.20 3.13 2.14
Total Current Liabilities
4.47 3.52 3.20 4.03 4.12 3.20 3.12 2.14
Accounts Payable
1.46 1.31 1.03 2.11 1.69 1.35 1.90 1.12
Current Employee Benefit Liabilities
- - - - - - 0.91 0.59
Other Current Liabilities
0.27 0.28 0.28 0.28 0.28 0.27 0.31 0.43
Total Noncurrent Liabilities
0.28 0.18 0.16 0.10 1.13 0.00 0.01 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
3.08 4.53 3.04 1.49 1.23 5.83 3.92 8.04
Total Preferred & Common Equity
3.08 4.53 3.04 1.49 1.23 5.83 2.53 6.74
Total Common Equity
3.08 4.53 3.04 1.49 1.23 5.83 2.53 6.74
Common Stock
637 642 642 643 643 650 89 95
Retained Earnings
-634 -638 -639 -641 -641 -644 -86 -89
Accumulated Other Comprehensive Income / (Loss)
-0.09 -0.10 -0.09 -0.09 -0.11 -0.11 -0.07 -0.12
Noncontrolling Interest
- - - - - - 1.39 1.30

Annual Metrics And Ratios for Vyome

This table displays calculated financial ratios and metrics derived from Vyome's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 16,772,818.00 17,441,817.00 23,280,439.00 7,694,576.00 7,770,698.00 17,784,027.00 24,176,434.00 13,135,478.00 712,680.00 2,693,338.00
DEI Adjusted Shares Outstanding
0.00 2.00 2.00 3.00 9.00 9.00 61.00 83.00 2,265.00 7,127.00 673,335.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -10,233,500.00 -17,382,500.00 -12,460,000.00 -2,630,666.67 -2,403,333.33 -1,035,180.33 -556,795.18 -5,027.37 -203.10 -15.24
Growth Metrics
- - - - - - - - - - -
Revenue Growth
14.13% -15.99% 192.19% -8.20% -63.95% 244.38% 20.36% -17.35% -22.79% -97.04% 24.43%
EBITDA Growth
-58.99% -31.01% -73.62% -6.99% 38.62% 61.11% -568.69% 23.64% 74.72% 89.08% -742.99%
EBIT Growth
-54.73% -33.43% -72.20% -7.48% 36.99% 48.28% -402.42% 23.19% 75.56% 89.07% -732.17%
NOPAT Growth
-51.76% -30.62% -76.32% -7.48% 37.16% 46.38% -364.65% 19.92% 66.81% 93.46% -938.67%
Net Income Growth
-57.30% -31.56% -69.86% -7.52% 36.66% 8.64% -191.94% 26.81% 75.36% 87.29% -623.87%
EPS Growth
-45.84% 82.13% 57.11% -7.52% 74.39% -10.14% -191.94% 62.31% 75.36% 87.29% 99.92%
Operating Cash Flow Growth
-14.99% -70.01% -58.12% 3.89% 22.31% 62.61% -79.82% -42.45% 22.56% 96.38% -510.43%
Free Cash Flow Firm Growth
0.00% -111.58% -67.79% 5.60% 23.59% -66.29% -21.15% 71.86% -23.83% 117.49% -403.94%
Invested Capital Growth
0.00% 58.82% 149.26% -209.92% 357.02% 1,252.17% -11.29% -101.37% 815.65% -142.94% -35.06%
Revenue Q/Q Growth
0.00% 0.00% 41.00% -15.21% -27.36% 64.44% -13.23% -0.28% -11.50% -95.70% -95.01%
EBITDA Q/Q Growth
0.00% 0.00% -7.54% 3.39% 14.23% 28.68% -154.61% 31.65% 55.86% 80.75% 17.61%
EBIT Q/Q Growth
0.00% 0.00% -7.46% 3.30% 13.46% 19.99% -138.02% 30.68% 56.39% 80.54% 17.63%
NOPAT Q/Q Growth
0.00% 0.00% -7.46% 3.30% 13.69% 17.26% -148.22% 30.40% 49.03% 84.38% 37.50%
Net Income Q/Q Growth
0.00% 0.00% -8.17% 3.52% 13.96% -14.10% -85.39% 30.42% 56.47% 76.01% 16.48%
EPS Q/Q Growth
0.00% 0.00% -8.33% 3.52% -10.79% -14.70% -85.39% 26.02% 56.47% 76.01% -8.24%
Operating Cash Flow Q/Q Growth
0.00% -8.75% -12.58% 11.39% 2.29% 26.72% -12.14% 2.65% 2.15% 79.98% 38.41%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 9.47% 1.91% -191.65% 44.75% -26.33% -65.34% 163.64% 24.60%
Invested Capital Q/Q Growth
0.00% 0.00% 1,033.93% -271.50% 161.90% 2,794.75% -59.32% -102.00% 37.16% -240.30% 31.46%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
38.03% 17.21% 51.29% 40.41% 10.09% 55.42% 61.38% 60.52% 63.93% 75.88% 68.43%
EBITDA Margin
-370.09% -577.19% -342.96% -399.71% -680.55% -76.85% -426.93% -394.48% -129.14% -476.41% -3,227.60%
Operating Margin
-369.72% -574.86% -346.89% -406.16% -708.02% -110.25% -425.60% -412.38% -177.26% -391.66% -3,269.35%
EBIT Margin
-370.56% -588.59% -346.89% -406.16% -709.88% -106.62% -445.05% -413.63% -130.92% -483.16% -3,231.35%
Profit (Net Income) Margin
-385.17% -603.21% -350.67% -410.72% -721.61% -191.43% -464.31% -411.16% -131.22% -563.34% -3,277.21%
Tax Burden Percent
100.26% 100.09% 100.69% 100.51% 100.00% 99.17% 99.57% 99.18% 100.46% 100.00% 100.00%
Interest Burden Percent
103.67% 102.39% 100.39% 100.61% 101.65% 181.05% 104.78% 100.22% 99.77% 116.59% 101.42%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% -2,967.34% -66.94% -177.02% -305.73% -1,189.85% -117.36% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% -2,914.11% 535.63% 169.91% -202.87% -1,175.31% 21.33% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 2,803.80% -75.66% -37.68% 113.15% 969.25% -10.06% 0.00%
Return on Equity (ROE)
3,535.68% -64.09% -69.94% -155.04% -163.53% -142.60% -214.70% -192.58% -220.59% -127.42% 3,331.46%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -4,094.13% 0.00% -1,045.32% -239.40% -165.05% 0.00% -625.77% 0.00% 0.00%
Operating Return on Assets (OROA)
-105.25% -42.95% -52.16% -88.55% -91.73% -41.94% -135.12% -146.03% -104.21% -20.61% -262.25%
Return on Assets (ROA)
-109.39% -44.02% -52.72% -89.55% -93.25% -75.30% -140.96% -145.16% -104.44% -24.04% -265.97%
Return on Common Equity (ROCE)
443,077.18% -9.20% -69.94% -155.04% -163.53% -142.59% -214.70% -192.58% -220.59% -127.42% 10,322.38%
Return on Equity Simple (ROE_SIMPLE)
28.21% -31.83% -99.01% -285.19% -149.38% -149.30% -142.43% -1,262.33% -170.90% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-10 -14 -24 -26 -16 -8.72 -41 -32 -11 -0.70 -7.32
NOPAT Margin
-258.80% -402.40% -242.83% -284.31% -495.61% -77.17% -297.92% -288.66% -124.09% -274.16% -2,288.55%
Net Nonoperating Expense Percent (NNEP)
-379.47% -19.96% -21.37% -47.65% -53.23% -602.57% -346.93% -102.86% -14.54% -138.69% -422.91%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - -161.61% 87.88% -194.49%
Cost of Revenue to Revenue
61.97% 82.79% 48.71% 59.59% 89.91% 44.58% 38.62% 39.48% 36.07% 24.12% 31.57%
SG&A Expenses to Revenue
86.43% 301.12% 290.79% 329.04% 508.02% 134.71% 244.21% 278.85% 118.97% 349.72% 739.90%
R&D to Revenue
321.32% 290.95% 107.39% 117.54% 210.09% 30.96% 17.42% 22.57% 26.68% 111.07% 184.00%
Operating Expenses to Revenue
407.75% 592.07% 398.18% 446.58% 718.10% 165.67% 486.99% 472.89% 241.20% 467.54% 3,337.78%
Earnings before Interest and Taxes (EBIT)
-15 -20 -34 -37 -23 -12 -61 -46 -11 -1.24 -10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-15 -20 -34 -36 -22 -8.68 -58 -44 -11 -1.22 -10
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 2.31 3.28 3.68 0.92 0.80 0.66 0.89 0.49 0.00 0.95
Price to Tangible Book Value (P/TBV)
0.00 2.31 3.28 3.68 0.92 0.00 1.24 0.96 0.49 0.00 1.09
Price to Revenue (P/Rev)
0.00 43.75 11.63 5.30 4.46 1.03 2.14 0.29 0.38 12.37 7.24
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 127.26 0.00 0.31 0.88 0.30 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 24.42 8.15 3.78 0.17 1.90 0.47 0.00 0.00 25.94 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.89 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-22.37 0.15 0.28 0.76 0.00 0.88 0.00 0.00 0.00 -0.82 0.00
Long-Term Debt to Equity
-20.67 0.15 0.23 0.00 0.00 0.63 0.00 0.00 0.00 0.00 0.00
Financial Leverage
6.11 -1.07 -1.01 -1.00 -0.96 -0.14 -0.22 -0.56 -0.82 -0.47 2.38
Leverage Ratio
-32.32 1.46 1.33 1.73 1.75 1.89 1.52 1.33 2.11 5.30 -12.53
Compound Leverage Factor
-33.51 1.49 1.33 1.74 1.78 3.43 1.60 1.33 2.11 6.18 -12.70
Debt to Total Capital
104.68% 13.32% 22.03% 43.10% 0.00% 46.86% 0.00% 0.00% 0.00% -447.77% 0.00%
Short-Term Debt to Total Capital
7.95% 0.00% 4.35% 43.10% 0.00% 13.24% 0.00% 0.00% 0.00% -447.77% 0.00%
Long-Term Debt to Total Capital
96.73% 13.32% 17.68% 0.00% 0.00% 33.63% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
581.84% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 35.09%
Common Equity to Total Capital
-586.52% 86.68% 77.97% 56.90% 100.00% 53.13% 100.00% 100.00% 100.00% 547.77% 64.91%
Debt to EBITDA
-0.66 -0.50 -0.29 -0.27 0.00 -1.47 0.00 0.00 0.00 -2.93 0.00
Net Debt to EBITDA
0.18 3.35 1.01 0.38 0.00 -1.13 0.00 0.00 0.00 -2.85 0.00
Long-Term Debt to EBITDA
-0.61 -0.50 -0.23 0.00 0.00 -1.06 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.94 -0.72 -0.41 -0.38 0.00 -1.47 0.00 0.00 0.00 -5.10 0.00
Net Debt to NOPAT
0.26 4.80 1.43 0.53 0.00 -1.12 0.00 0.00 0.00 -4.95 0.00
Long-Term Debt to NOPAT
-0.87 -0.72 -0.33 0.00 0.00 -1.05 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 5.12 -0.10 -8.44 -12.68 -19.99 -16.30 -90.67 -84.92 -63.33 -23.06
Noncontrolling Interest Sharing Ratio
-12,431.59% 85.65% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -209.85%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.48 17.00 5.17 1.66 4.59 0.77 3.98 1.32 2.73 0.05 1.99
Quick Ratio
2.37 16.55 4.86 1.43 3.61 0.48 3.40 0.81 1.62 0.02 1.82
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-7.32 -15 -26 -25 -19 -31 -38 -11 -13 2.30 -7.00
Operating Cash Flow to CapEx
-8,565.41% -5,502.27% -2,936.15% -2,295.79% -11,786.60% -2,192.31% -4,367.90% -23,806.52% -169,600.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 -4.04 -18.33 0.00 0.00 11.18 -47.74
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 -1.11 -7.46 0.00 0.00 -2.98 -25.56
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -1.16 -7.63 0.00 0.00 -2.98 -25.56
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.28 0.07 0.15 0.22 0.13 0.39 0.30 0.35 0.80 0.04 0.08
Accounts Receivable Turnover
6.35 5.90 4.18 3.57 5.68 7.78 5.00 4.50 4.52 0.00 0.00
Inventory Turnover
6.90 4.72 4.30 3.62 1.68 2.41 2.00 1.34 0.85 0.00 0.00
Fixed Asset Turnover
9.66 5.98 9.61 5.90 2.33 13.57 13.35 10.45 22.90 4.31 6.06
Accounts Payable Turnover
4.56 4.91 5.16 4.45 3.27 2.34 1.47 1.65 1.73 0.05 0.09
Days Sales Outstanding (DSO)
57.47 61.91 87.22 102.13 64.24 46.92 72.93 81.10 80.73 0.00 0.00
Days Inventory Outstanding (DIO)
52.93 77.31 84.84 100.89 217.52 151.45 182.33 271.98 428.67 0.00 0.00
Days Payable Outstanding (DPO)
80.06 74.33 70.71 81.95 111.79 155.91 247.51 221.81 210.78 7,817.24 4,072.03
Cash Conversion Cycle (CCC)
30.35 64.90 101.35 121.08 169.97 42.46 7.74 131.27 298.63 -7,817.24 -4,072.03
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-3.13 -1.29 0.64 -0.70 1.79 24 22 -0.29 2.10 -0.90 -1.22
Invested Capital Turnover
-2.58 -1.54 -30.32 -288.92 5.99 0.87 0.59 1.06 9.59 0.43 -0.30
Increase / (Decrease) in Invested Capital
-3.13 1.84 1.92 -1.33 2.49 22 -2.74 -22 2.40 -3.01 -0.32
Enterprise Value (EV)
0.00 83 81 34 0.56 21 6.35 -0.70 -1.28 6.67 -1.35
Market Capitalization
0.00 148 115 48 15 12 29 3.26 3.28 3.18 2.32
Book Value per Share
($96.20) $3.83 $2.01 $0.56 $2.06 $1.86 $2.49 $0.15 $0.51 ($6.16) $1.13
Tangible Book Value per Share
($96.20) $3.83 $2.01 $0.56 $2.06 ($1.61) $1.32 $0.14 $0.51 ($6.60) $0.98
Total Capital
9.40 74 45 23 16 27 44 3.66 6.66 -0.80 3.76
Total Debt
9.84 9.88 9.92 9.93 0.00 13 0.00 0.00 0.00 3.59 0.00
Total Long-Term Debt
9.09 9.88 7.96 0.00 0.00 9.17 0.00 0.00 0.00 0.00 0.00
Net Debt
-2.69 -66 -34 -14 -14 9.77 -23 -3.96 -4.56 3.49 -4.98
Capital Expenditures (CapEx)
0.13 0.35 1.04 1.28 0.19 0.39 0.35 0.09 0.01 -0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3.55 -2.01 -0.70 -2.39 0.20 -2.06 -0.41 -1.53 1.96 -1.95 -2.28
Debt-free Net Working Capital (DFNWC)
8.98 73 44 21 14 0.95 22 2.43 6.52 -1.85 2.70
Net Working Capital (NWC)
8.24 73 42 11 14 -2.66 22 2.43 6.52 -5.44 2.70
Net Nonoperating Expense (NNE)
5.10 6.81 11 12 7.42 13 23 14 0.62 0.74 3.16
Net Nonoperating Obligations (NNO)
-2.69 -66 -34 -14 -14 9.77 -23 -3.96 -4.56 3.49 -4.98
Total Depreciation and Amortization (D&A)
0.02 0.39 0.39 0.59 0.96 3.36 2.47 2.15 0.15 0.02 0.01
Debt-free, Cash-free Net Working Capital to Revenue
-87.84% -59.12% -7.04% -26.25% 6.19% -18.22% -2.99% -13.57% 22.59% -759.00% -712.88%
Debt-free Net Working Capital to Revenue
222.41% 2,165.31% 440.81% 234.55% 434.56% 8.39% 164.76% 21.62% 75.12% -719.34% 845.49%
Net Working Capital to Revenue
203.91% 2,165.31% 421.06% 125.44% 434.56% -23.55% 164.76% 21.62% 75.12% -2,116.30% 845.49%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($40,710.00) ($7,275.00) ($3,120.00) ($2,940.00) ($754.50) ($238.50) ($250.00) $0.00 ($110.78) ($1,383.00) ($4.86)
Adjusted Weighted Average Basic Shares Outstanding
382.00 11.18K 11.74K 15.67K 51.54K 66.80K 247.57K 0.00 102.70K 5.16K 2.16M
Adjusted Diluted Earnings per Share
($40,710.00) ($7,275.00) ($3,120.00) ($2,940.00) ($754.50) ($238.50) ($250.00) $0.00 ($110.78) ($1,383.00) ($4.86)
Adjusted Weighted Average Diluted Shares Outstanding
382.00 11.18K 11.74K 15.67K 51.54K 66.80K 247.57K 0.00 102.70K 5.16K 2.16M
Adjusted Basic & Diluted Earnings per Share
($40,710.00) ($7,275.00) ($3,120.00) ($2,940.00) ($754.50) ($238.50) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
382.00 2.82K 11.15K 12.69K 31.38K 51.59K 0.00 0.00 404.43K 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-10 -14 -24 -26 -16 -8.72 -19 -19 -10 -0.70 -7.32
Normalized NOPAT Margin
-258.80% -402.40% -242.83% -284.31% -495.61% -77.17% -140.17% -168.64% -118.08% -274.16% -2,288.55%
Pre Tax Income Margin
-384.15% -602.65% -348.26% -408.65% -721.61% -193.03% -466.32% -414.54% -130.62% -563.34% -3,277.21%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 -1.56 -29.37 0.00 0.00 -6.03 -70.45
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 -1.13 -19.66 0.00 0.00 -3.42 -49.90
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -1.61 -29.54 0.00 0.00 -6.02 -70.45
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 -1.18 -19.83 0.00 0.00 -3.42 -49.90
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Vyome

This table displays calculated financial ratios and metrics derived from Vyome's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
3,452,447.00 13,135,478.00 23,457,090.00 23,457,090.00 29,387,152.00 712,680.00 712,680.00 738,277.00 2,693,338.00 2,693,338.00 2,693,338.00
DEI Adjusted Shares Outstanding
595.00 2,265.00 4,044.00 4,044.00 5,067.00 7,127.00 7,127.00 184,569.00 673,335.00 673,335.00 673,335.00
DEI Earnings Per Adjusted Shares Outstanding
-5,939.50 -749.67 -542.28 -394.41 -108.11 405.26 -41.25 -14.25 -12.53 -1.00 -1.43
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-22.98% -36.27% -15.00% -12.82% -96.08% -288.53% -89.78% -36.79% -59.03% 44.60% -84.09%
EBITDA Growth
71.04% 89.47% 15.98% 41.91% 85.62% 307.67% 89.21% -31.34% -1,609.63% -117.76% -316.17%
EBIT Growth
71.89% 89.76% 17.28% 42.55% 85.78% 306.58% 89.08% -31.15% -1,604.84% -117.86% -311.13%
NOPAT Growth
68.46% 88.64% 60.75% 48.34% 92.76% 366.62% 91.00% -34.47% -2,951.59% -38.88% -467.81%
Net Income Growth
71.00% 89.69% 17.62% 54.34% 84.50% 270.10% 86.59% -64.89% -1,469.14% -125.15% -235.24%
EPS Growth
71.00% 89.69% 17.62% 54.34% 84.50% 270.10% 86.59% 97.54% 99.78% -100.00% 99.98%
Operating Cash Flow Growth
47.28% 13.15% 59.06% 79.63% 201.36% 99.88% 90.18% -231.17% 54.10% -49,704.51% -605.52%
Free Cash Flow Firm Growth
-64.69% -136.78% -123.98% -107.82% -93.36% 275.73% 166.99% -32.72% -616.02% -62.12% -143.07%
Invested Capital Growth
-89.56% 815.65% 255.09% -9.13% -58.02% -142.94% -167.40% -14.67% -376.46% -35.06% 45.53%
Revenue Q/Q Growth
-4.39% -8.03% -1.92% 1.08% -95.70% -4,520.63% 105.31% 11.59% -97.21% -6,077.74% 101.53%
EBITDA Q/Q Growth
-0.90% 52.12% -30.74% 8.02% 75.03% 791.58% -106.79% -275.62% -225.05% 92.81% -59.18%
EBIT Q/Q Growth
-0.91% 52.60% -30.55% 8.00% 75.03% 788.77% -106.90% -276.35% -224.61% 92.78% -58.91%
NOPAT Q/Q Growth
2.41% 51.13% -16.56% 7.06% 86.32% 1,899.14% -103.94% 11.94% -210.44% 136.03% -136.57%
Net Income Q/Q Growth
-1.17% 51.95% -29.15% 27.27% 65.66% 627.28% -110.18% -278.43% -226.82% 91.55% -35.67%
EPS Q/Q Growth
-1.17% 51.95% -29.15% 27.27% 65.66% 627.28% -110.18% -111.85% -38.67% 90.06% 51.61%
Operating Cash Flow Q/Q Growth
58.27% 11.62% 15.67% 34.51% 307.65% -100.11% -6,757.58% -112.08% 196.63% -134.04% 2.86%
Free Cash Flow Firm Q/Q Growth
-34.56% -135.66% -32.26% 74.65% 155.52% 844.18% -49.58% -233.19% -115.86% 169.31% -157.33%
Invested Capital Q/Q Growth
-25.93% 37.16% -2.33% -8.42% -65.78% -240.30% -53.29% 215.96% -210.86% 31.46% 38.17%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
59.77% 92.94% 59.93% 57.71% 43.87% 0.00% 77.76% 48.23% 52.13% 0.00% 52.69%
EBITDA Margin
-161.76% -84.21% -112.24% -102.14% -592.94% 0.00% -118.59% -212.24% -24,744.85% 0.00% -3,102.37%
Operating Margin
-180.05% -95.66% -113.68% -104.53% -332.42% 0.00% -100.21% -222.38% -24,761.92% 0.00% -3,576.78%
EBIT Margin
-164.08% -84.56% -112.55% -102.44% -594.69% 0.00% -120.36% -212.56% -24,748.60% 0.00% -3,110.62%
Profit (Net Income) Margin
-163.99% -85.67% -112.81% -81.17% -648.05% 0.00% -148.04% -211.76% -24,822.54% 0.00% -3,119.63%
Tax Burden Percent
100.09% 101.86% 100.64% 100.95% 99.88% 100.99% 100.00% 100.31% 100.00% 97.98% 100.00%
Interest Burden Percent
99.86% 99.46% 99.59% 78.49% 109.10% 82.60% 122.99% 99.32% 100.30% 119.90% 100.29%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-152.29% -642.10% -1,817.22% -297.86% -1,276.82% 0.00% 0.00% -575.90% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-131.30% -633.39% -1,806.04% -292.46% -1,247.46% 0.00% 0.00% -549.99% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
42.60% 522.35% 1,698.78% 174.17% 652.94% 0.00% 0.00% 333.57% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-109.69% -119.76% -118.43% -123.70% -623.88% 0.00% 15.67% -242.34% -464.18% 3,331.46% -240.94%
Cash Return on Invested Capital (CROIC)
-98.12% -625.77% -571.94% -346.02% -332.29% 0.00% 0.00% -322.61% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
-88.69% -67.31% -76.32% -90.35% -528.73% 0.00% 0.00% -177.87% -25,029.71% 0.00% -57.00%
Return on Assets (ROA)
-88.64% -68.19% -76.50% -71.59% -576.17% 0.00% 0.00% -177.19% -25,104.49% 0.00% -57.17%
Return on Common Equity (ROCE)
-109.69% -119.76% -118.43% -123.70% -623.88% 0.00% 15.67% -242.34% -344.92% 10,322.38% -207.23%
Return on Equity Simple (ROE_SIMPLE)
-848.46% 0.00% -240.80% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-2.72 -1.33 -1.55 -1.44 -0.20 3.54 -0.14 -1.93 -6.00 2.16 -0.79
NOPAT Margin
-126.03% -66.96% -79.58% -73.17% -232.69% 0.00% -70.15% -155.67% -17,333.34% 0.00% -2,503.74%
Net Nonoperating Expense Percent (NNEP)
-20.99% -8.71% -11.17% -5.40% -29.36% -121.39% -6.07% -25.92% -79.28% -386.56% -3.41%
Return On Investment Capital (ROIC_SIMPLE)
- -19.92% -34.12% -47.37% -13.23% -441.43% -11.33% -33.17% -152.85% 57.49% -9.84%
Cost of Revenue to Revenue
40.23% 7.06% 40.07% 42.29% 56.13% 0.00% 22.24% 51.77% 47.87% 0.00% 47.31%
SG&A Expenses to Revenue
178.61% -229.52% 96.30% 97.00% 292.01% 0.00% 130.74% 128.10% 2,438.40% 0.00% 1,511.74%
R&D to Revenue
25.15% 37.29% 24.90% 20.31% 79.05% 0.00% 45.46% 38.33% 114.58% 0.00% 2,109.48%
Operating Expenses to Revenue
239.81% 188.60% 173.61% 162.24% 376.29% 0.00% 177.97% 270.61% 24,814.05% 0.00% 3,629.47%
Earnings before Interest and Taxes (EBIT)
-3.54 -1.68 -2.19 -2.01 -0.50 3.46 -0.24 -2.64 -8.57 -0.62 -0.98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-3.49 -1.67 -2.18 -2.01 -0.50 3.47 -0.24 -2.64 -8.57 -0.62 -0.98
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.38 0.49 0.53 1.48 1.93 0.00 0.21 0.31 1.38 0.95 0.00
Price to Tangible Book Value (P/TBV)
0.38 0.49 0.53 1.48 1.93 0.00 0.21 0.31 1.57 1.09 0.00
Price to Revenue (P/Rev)
0.12 0.38 0.29 0.56 0.48 12.37 0.00 0.28 0.54 7.24 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.57 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 175.76% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 1.78 3.14 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.42 0.34 25.94 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 2.89 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 -0.82 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.32 -0.82 -0.94 -0.60 -0.52 -0.47 -0.88 -0.61 -1.21 2.38 -1.23
Leverage Ratio
1.51 2.11 2.00 1.87 2.94 5.30 2.55 1.74 2.34 -12.53 1.80
Compound Leverage Factor
1.51 2.10 1.99 1.47 3.21 4.38 3.14 1.73 2.35 -15.02 1.80
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% -447.77% 0.00% 0.00% 0.21% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% -447.77% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.21% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 35.37% 35.09% 16.13%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 547.77% 100.00% 100.00% 64.42% 64.91% 83.87%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -2.93 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -2.85 0.00 0.00 0.46 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -5.10 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -4.95 0.00 0.00 0.49 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
-113.02 -81.93 -107.31 -138.45 -158.34 -52.10 -138.39 -99.01 -19.10 -18.13 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 25.69% -209.85% 13.99%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.66 2.73 2.24 1.90 1.33 0.05 1.53 2.77 1.94 1.99 4.27
Quick Ratio
0.81 1.62 1.12 0.76 0.52 0.02 0.79 1.72 1.84 1.82 4.10
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
10 -3.73 -4.93 -1.25 0.69 6.55 3.30 -1.66 -3.58 2.48 -1.42
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 15.16 11.11 60.06 0.00 -139.73 17.10 -499.65
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 61.60 -0.01 -3.70 0.00 169.60 -10.19 -504.73
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 61.60 -0.01 -3.70 0.00 169.60 -10.19 -504.73
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.54 0.80 0.68 0.88 0.89 0.04 0.00 0.84 1.01 0.08 0.02
Accounts Receivable Turnover
4.47 4.52 4.52 4.79 3.42 0.00 0.00 5.98 9.37 0.00 0.00
Inventory Turnover
1.22 0.85 0.82 0.80 0.59 0.00 0.00 0.83 0.00 0.00 0.00
Fixed Asset Turnover
20.30 22.90 22.96 22.76 105.76 4.31 0.00 165.44 137.43 6.06 3.89
Accounts Payable Turnover
2.61 1.73 1.72 1.99 1.01 0.05 0.00 2.03 1.19 0.09 0.05
Days Sales Outstanding (DSO)
81.57 80.73 80.82 76.14 106.80 0.00 0.00 61.01 38.97 0.00 0.00
Days Inventory Outstanding (DIO)
299.10 428.67 446.31 454.26 623.21 0.00 0.00 438.33 0.00 0.00 0.00
Days Payable Outstanding (DPO)
140.08 210.78 212.32 183.48 362.17 7,817.24 0.00 179.63 306.97 4,072.03 7,145.28
Cash Conversion Cycle (CCC)
240.59 298.63 314.81 346.93 367.84 -7,817.24 0.00 319.72 -268.01 -4,072.03 -7,145.28
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1.53 2.10 2.06 1.88 0.64 -0.90 -1.39 1.61 -1.78 -1.22 -0.75
Invested Capital Turnover
1.21 9.59 22.84 4.07 5.49 0.43 0.00 3.70 -11.27 -0.30 -0.14
Increase / (Decrease) in Invested Capital
-13 2.40 3.38 -0.19 -0.89 -3.01 -3.44 -0.28 -2.42 -0.32 0.63
Enterprise Value (EV)
-0.38 -1.28 -0.06 3.34 2.02 6.67 -2.36 -2.42 -0.82 -1.35 0.00
Market Capitalization
1.17 3.28 2.42 4.49 2.86 3.18 0.26 1.80 3.49 2.32 0.00
Book Value per Share
$0.89 $0.51 $0.35 $0.13 $0.05 ($6.16) $1.73 $7.90 $0.94 $1.13 $1.01
Tangible Book Value per Share
$0.89 $0.51 $0.35 $0.13 $0.05 ($6.60) $1.73 $7.90 $0.82 $0.98 $0.96
Total Capital
3.08 6.66 4.53 3.04 1.49 -0.80 1.23 5.83 3.93 3.76 8.04
Total Debt
0.00 0.00 0.00 0.00 0.00 3.59 0.00 0.00 0.01 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Net Debt
-1.55 -4.56 -2.48 -1.15 -0.84 3.49 -2.62 -4.22 -5.70 -4.98 -8.80
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1.38 1.96 1.90 1.73 0.47 -1.95 -0.44 1.44 -2.79 -2.28 -1.78
Debt-free Net Working Capital (DFNWC)
2.93 6.52 4.38 2.89 1.31 -1.85 2.17 5.66 2.92 2.70 7.02
Net Working Capital (NWC)
2.93 6.52 4.38 2.89 1.31 -5.44 2.17 5.66 2.92 2.70 7.02
Net Nonoperating Expense (NNE)
0.82 0.37 0.65 0.16 0.35 0.65 0.15 0.70 2.59 2.89 0.19
Net Nonoperating Obligations (NNO)
-1.55 -4.56 -2.48 -1.15 -0.84 3.49 -2.62 -4.22 -5.70 -4.98 -8.80
Total Depreciation and Amortization (D&A)
0.05 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
14.08% 22.59% 22.76% 21.54% 7.87% -759.00% 0.00% 22.32% -43.56% -712.88% -1,163.75%
Debt-free Net Working Capital to Revenue
29.88% 75.12% 52.50% 35.87% 21.97% -719.34% 0.00% 87.77% 45.59% 845.49% 4,595.52%
Net Working Capital to Revenue
29.88% 75.12% 52.50% 35.87% 21.97% -2,116.30% 0.00% 87.77% 45.59% 845.49% 4,595.52%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($59.16) ($958.74) ($130.50) ($87.00) ($311.00) $1,198,469.00 $75.92 ($2.25) ($3.12) ($0.31) ($0.15)
Adjusted Weighted Average Basic Shares Outstanding
59.53K 1.77K 16.18K 17.40K 5.09K 2.00 19.42K 1.17M 2.76M 2.16M 6.69M
Adjusted Diluted Earnings per Share
($59.16) ($958.74) ($130.50) ($87.00) ($311.00) $1,198,469.00 $75.92 ($2.25) ($3.12) ($0.31) ($0.15)
Adjusted Weighted Average Diluted Shares Outstanding
59.53K 1.77K 16.18K 17.40K 5.09K 2.00 19.42K 1.17M 2.76M 2.16M 6.69M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($958.74) $0.00 $0.00 $0.00 $1,198,469.00 $0.00 $0.00 $0.00 ($0.31) $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
226.47K 404.43K 16.18K 20.27K 7.13K 0.00 184.57K 2.69M 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-2.17 -1.33 -1.55 -1.29 -0.20 2.48 -0.14 -1.44 -6.00 2.16 -0.79
Normalized NOPAT Margin
-100.79% -66.96% -79.58% -65.58% -232.69% 0.00% -70.15% -115.60% -17,333.34% 0.00% -2,503.74%
Pre Tax Income Margin
-163.85% -84.11% -112.09% -80.41% -648.81% 0.00% -148.04% -211.11% -24,822.54% 0.00% -3,119.63%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 -10.99 5.88 -4.35 0.00 -334.70 -4.26 -345.40
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 -4.30 6.01 -2.53 0.00 -234.42 14.91 -278.02
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -10.99 5.88 -4.35 0.00 -334.70 -4.26 -345.40
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -4.30 6.01 -2.53 0.00 -234.42 14.91 -278.02
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Vyome (NASDAQ:HIND) continues to operate with very limited revenue and significant losses, but its Q1 2026 balance sheet shows a stronger cash position than a year ago. The company ended the quarter with $8.8 million in cash and equivalents, up from $5.7 million at the end of Q3 2025 and well above the $2.5 million reported at Q1 2025. That improvement was driven primarily by $5.3 million of common equity issuance, which helped offset a $1.4 million operating cash burn.

Quarter-over-quarter, the business remains highly challenged operationally. Q1 2026 revenue was just $31.6 thousand, down sharply from $2.07 million in Q4 2025 and also below the $34.6 thousand reported in Q3 2025. Gross profit was only $16.6 thousand, while operating expenses totaled $1.15 million, leading to an operating loss of $1.13 million and a net loss of $985.5 thousand for the quarter.

Over the last several years, the trend is clear: revenue has been volatile and generally weak, while losses have persisted. The company reported quarterly net losses in most periods shown, including:

  • Q1 2025 net loss of $294.0 thousand, which was relatively modest versus later periods.
  • Q4 2024 net income of $2.89 million, but that result appears to have been unusually strong and not consistently repeated.
  • Q2 2025 net loss of $2.63 million.
  • Q3 2025 net loss of $8.60 million.
  • Q1 2026 net loss of $985.5 thousand.

Cash flow remains a key concern. In Q1 2026, operating activities used $1.44 million of cash, marking another quarter of negative operating cash flow. That is an improvement from the much larger operating outflows seen in Q2 2025 ($4.49 million) and Q3 2025 ($4.34 million), but it still indicates the core business is not self-funding.

The balance sheet improved on cash, but leverage and liquidity still need monitoring. As of Q1 2026, total assets were $10.2 million versus total liabilities of $2.1 million, and total equity plus noncontrolling interests was $8.0 million. However, the company’s retained earnings remain deeply negative at $(88.5) million, reflecting a long history of losses and likely prior dilution/restructuring activity.

  • Cash and equivalents increased to $8.8 million in Q1 2026, giving the company more near-term flexibility.
  • Operating cash burn improved versus Q2 and Q3 2025, suggesting some quarter-to-quarter stabilization.
  • Gross profit was positive in Q1 2026, with revenue exceeding direct cost of revenue.
  • The company recorded $144.4 thousand of total other income in Q1 2026, which partially offset operating losses.
  • Noncontrolling interest of $1.3 million helps support total equity, but it does not directly solve the company’s operating losses.
  • Q1 2026 operating revenue was only $31.6 thousand, indicating very limited sales volume.
  • Operating expenses of $1.15 million dwarfed revenue, producing a large operating loss.
  • The company burned $1.4 million in operating cash in Q1 2026.
  • Recent quarters have shown heavy reliance on equity issuance to fund operations.
  • The long-term pattern remains one of recurring losses, dilution, and unstable results.

Bottom line: Vyome’s latest quarter shows a healthier cash balance than in prior periods, but the underlying business remains fragile. Until revenue becomes more consistent and operating losses narrow materially, the company will likely continue to depend on external financing to support operations.

07/25/26 04:38 PM ETAI Generated. May Contain Errors.

Vyome Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Vyome's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Vyome's net income appears to be on a downward trend, with a most recent value of -$10.48 million in 2025, falling from -$15.56 million in 2015. The previous period was -$1.45 million in 2024. View Vyome's forecast to see where analysts expect Vyome to go next.

Vyome's total operating income in 2025 was -$10.45 million, based on the following breakdown:
  • Total Gross Profit: $218.77 thousand
  • Total Operating Expenses: $10.67 million

Over the last 10 years, Vyome's total revenue changed from $4.04 million in 2015 to $319.71 thousand in 2025, a change of -92.1%.

Vyome's total liabilities were at $2.74 million at the end of 2025, a 52.6% decrease from 2024, and a 81.3% decrease since 2015.

In the past 10 years, Vyome's cash and equivalents has ranged from $101.90 thousand in 2024 to $72.98 million in 2016, and is currently $4.98 million as of their latest financial filing in 2025.

Over the last 10 years, Vyome's book value per share changed from -96.20 in 2015 to 1.13 in 2025, a change of -101.2%.



Financial statements for NASDAQ:HIND last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners